KCM
ABEO icon

Kennedy Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Kennedy Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.66M Sell
1,240,071
-23,440
-2% -$129K 0.14% 250
2026
Q1 		$5.66M Buy
1,263,511
+213,416
+20% +$1.07M 0.12% 267
2025
Q4 		$5.53M Sell
1,050,095
-768
-0.1% -$3.87K 0.12% 278
2025
Q3 		$5.55M Buy
1,050,863
+378,860
+56% +$2.4M 0.12% 279
2025
Q2 		$3.82M Buy
672,003
+50,240
+8% +$286K 0.09% 335
2025
Q1 		$2.96M Buy
+621,763
New +$3.38M 0.07% 370

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kennedy Capital Management's ABEO Position: Q2 2026 in Review

Kennedy Capital Management reduced its Abeona Therapeutics (ABEO) stake by 1.9% in Q2 2026, selling an estimated $129K and leaving 1,240,071 shares worth $7.66M. The position accounts for 0.14% of the portfolio, ranked #250.

Kennedy Capital Management first reported a position in ABEO in Q1 2025 and has held it in 6 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Kennedy Capital Management held 1,240,071 shares of Abeona Therapeutics worth $7.66M as of Q2 2026.
  • Kennedy Capital Management sold 23,440 Abeona Therapeutics shares in Q2 2026, an estimated $129K.
  • Abeona Therapeutics made up 0.14% of Kennedy Capital Management's portfolio in Q2 2026, its #250 holding.
  • Kennedy Capital Management first reported a position in Abeona Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.